Test Price
2,800 AED✅ Home Collection Available
AIMP1 Gene Leukodystrophy Hypomyelinating Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين AIMP1 لمرض حثل المادة البيضاء ناقص الميالين النوع الثالث في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي معتمد من هيئة الصحة بدبي (Executive Summary)
تحليل جين AIMP1 عبر التسلسل الجيني من الجيل التالي (NGS) يُجرى بدقة تشخيصية 99.9% في مختبر معتمد آيزو 9001:2015، مع خدمة سحب منزلي فاخرة وسلسلة تبريد فائقة الجودة، وفقًا للقانون الاتحادي رقم 41 لسنة 2024 (المادة 87) وقانون البيانات الشخصية الإماراتي.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) processing in a DHA-licensed facility (License 9834453).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM‑11 PM daily).
- ✓ Clinical Guidance: Complimentary telephonic post‑test clinical guidance with a certified genetic counsellor to interpret results.
- ✓ Insurance & Billing: Direct Billing Verification via WhatsApp +971 54 548 8731. All major UAE insurers accepted; minors require guardian consent per CDS Law 2026.
Test Overview
This test sequences the entire AIMP1 gene using Next‑Generation Sequencing (NGS) to diagnose Leukodystrophy, Hypomyelinating Type 3 (HLD3) – a rare autosomal recessive neurological disorder that disrupts myelin formation. The panel provides definitive genetic confirmation for symptomatic patients, carrier screening, and family planning.
يقوم الاختبار بتحليل شامل لجين AIMP1 لتأكيد تشخيص حثل المادة البيضاء ناقص الميالين النوع الثالث، ويخدم المرضى الذين يعانون من تأخر حركي وتدهور عصبي، إضافة إلى فحص حاملي المرض والتخطيط العائلي.
| Feature | Our Test (AIMP1 NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | NGS (Next‑Generation Sequencing), full gene coverage, deep intronic regions | Sanger sequencing of targeted exons only |
| Diagnostic Yield | >99% for known pathogenic variants | ~80% – misses deep intronic/novel variants |
| Turnaround Time | 3‑4 weeks (cold‑chain verified) | 4‑8 weeks (may require multiple referrals) |
| Clinical Reporting | DHA‑aligned report with ICD‑10‑CM, LOINC, and genetic counselling note | Standard laboratory printout |
| Specimen Logistics | Hospital‑grade home collection, ISO cold‑chain, WhatsApp tracking | Requires clinic visit, dry ice not guaranteed |
Physician Insight & Safety Protocol
"As a neurologist, I understand the uncertainty that a suspected leukodystrophy brings to families. This test is a powerful tool to confirm the exact AIMP1 mutation, but a negative result does not rule out all genetic leukodystrophies; clinical correlation and further sequencing panels remain essential. Please reach out for a post‑test consultation to ensure the result is placed in the full context of your child’s symptoms and development."
— Dr. Prabhakar Reddy, DHA‑61713011 (Consultant Neurologist)
Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
- ⚠️ Exclusion Criteria: Acute febrile illness within 48 hours, active infection at venipuncture site, known bleeding diathesis without medical clearance, or lack of signed informed consent (mandatory for minors under CDS Law 2026).
- 🚨 Emergency Red Flags: If the patient experiences rapid neurological deterioration, new‑onset seizures, or loss of consciousness, go directly to the nearest Emergency Department. Do not wait for test results.
Frequently Asked Questions
1. What is the AIMP1 gene test and who should consider it?
The AIMP1 gene test uses next-generation sequencing to detect mutations causing hypomyelinating leukodystrophy type 3, a rare neurological disorder. يُوصى بهذا التحليل للأطفال الذين يعانون من تأخر حركي وضعف عضلي، وللأقارب للتخطيط العائلي، وللأزواج الذين يحملون طفرات متنحية.
2. How is the sample collected, and is home service available across all Emirates?
A certified mobile phlebotomist collects a 2 mL blood sample in a special DNA tube between 8 AM and 11 PM, even in remote areas. يتم سحب عينة دم بسيطة من المنزل عبر فريق تمريض مرخص، مع سلسلة تبريد فائقة تضمن سلامة العينة حتى وصولها إلى المختبر في دبي.
3. Will insurance cover this test, and what do I need to provide?
Most UAE insurers reimburse this genetic test when a neurologist provides a referral letter and clinical notes. نحن نتحقق مباشرة من التغطية التأمينية عبر واتساب +971545488731؛ أحضر بطاقة التأمين وتقرير الطبيب المختص.
This service complies with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE Personal Data Protection Law (PDPL), and CDS Law 2026 for minors. Laboratory ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139), DHA Facility License 9834453. Price: 2800 AED. Turnaround time: 3‑4 working weeks.
All clinical decisions must be guided by a qualified healthcare professional. results are for clinical use only and do not constitute sole diagnostic evidence.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians